VAM
BIIB icon

Visionary Asset Management’s Biogen BIIB Stock Holding History

Visionary Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-699
Closed -$219K – 278
2017
Q3 		$219K Buy
+699
New +$207K 0.06% 206
2014
Q3 		– Sell
-33
Closed -$10K – 149
2014
Q2 		$10K Buy
+33
New +$9.93K ﹤0.01% 270

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Visionary Asset Management's BIIB Position: Q4 2017 in Review

Visionary Asset Management sold out of Biogen (BIIB) in Q4 2017, closing a stake of 699 shares — an estimated $219K sold.

Visionary Asset Management first reported a position in BIIB in Q2 2014 and held it in 2 quarters. The position peaked at $219K in Q3 2017. 1,122 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • Visionary Asset Management reported no remaining Biogen position as of Q4 2017 after selling out during the quarter.
  • Visionary Asset Management sold 699 Biogen shares in Q4 2017, an estimated $219K.
  • Visionary Asset Management first reported a position in Biogen in Q2 2014 and held it in 2 quarters.
  • Visionary Asset Management's Biogen position peaked at $219K in Q3 2017.
  • 1,122 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Visionary Asset Management's 13F filing for Q4 2017, filed 11 Jan 2018.